Mulberry Compound for Equine Insulin Dysregulation Management

Research indicates that a compound derived from mulberry may provide a safe and effective method for managing insulin dysregulation (ID) in horses. This condition is recognized as a primary feature of equine metabolic syndrome and is considered one of the most difficult metabolic issues for horse owners and veterinarians to manage.

The findings suggest that mulberry extract can help lower glucose and insulin spikes in affected horses, offering a potential therapeutic option for stabilizing metabolic health.

Efficacy and Administration of 1-Deoxynojirimycin

According to Michelle Coleman, DVM, PhD, DACVIM, the specific mulberry extract containing 5% 1-deoxynojirimycin has been evaluated for both safety and efficacy in horses with insulin dysregulation.

The research identifies specific protocols for the administration of this compound to achieve optimal effects:

• The recommended dosage is 500 mg administered twice daily.
• The extract should be given one hour before feeding.

Context of Insulin Dysregulation in Equine Health

Insulin dysregulation is a critical component of equine metabolic syndrome. When horses experience ID, they struggle to maintain normal insulin levels, which can lead to significant health complications if not properly managed.

Because the condition is challenging to treat, the introduction of a mulberry-derived compound represents a promising development in equine veterinary medicine. The ability to mitigate insulin and glucose spikes is essential for preventing the progression of metabolic syndrome and its associated risks.

The use of 1-deoxynojirimycin, a compound found in mulberry extracts, targets the metabolic response to feeding, which is why the timing of administration—specifically the window before food intake—is a key factor in its effectiveness.